Abstract: A health monitoring and insulin delivery system, comprising an elongated member 101 adapted to be worn around a waist of a user, the member 101 is composed of multiple section connected with each other by means of hinges 102, a circular sliding unit 103 is arranged along member 101, a delivery unit 104 delivers insulin to user, the delivery unit 104 comprising cuboidal box 201, an imaging unit 202 that locate abdomen of user, a chamber 203 is provided within the box 201 to store insulin, connected with an injector 204 via a conduit, the injector 204 injects insulin into abdomen of user, a band 301 adapted to be worn over arm of user, having a sensing unit to detect health parameters of user and input parameters into a dosage module to determine an accurate dosage of insulin based on medical details input by user and readings of sensing unit.
Description:FIELD OF THE INVENTION
[0001] The present invention relates to a health monitoring and insulin delivery system that is developed to facilitate automated and precise delivery of insulin to a user, customized to the user's individual medical requirements, thereby optimizing insulin dosage and enhancing user wellbeing.
BACKGROUND OF THE INVENTION
[0002] Managing conditions such as diabetes requires individuals to monitor health parameters and receive accurate medication doses, particularly insulin. Traditional methods often involve manual monitoring of blood glucose levels and administering insulin through syringes or insulin pens. These methods rely heavily on user precision and are quite inconvenient, requiring continuous focus on the procedure. Additionally, conventional approaches often lack automation and personalized adjustments for insulin delivery, which may result in errors in dosage and discomfort during injections. Hence, there is a need exists for an efficient, automated system that integrates health monitoring with insulin delivery to enhance medication accuracy and user experience.
[0003] Conventionally, insulin pens were used as these equipment’s had prefilled insulin cartridges, and the user adjust the dosage using a dial on the pen. Insulin pens allowed for more precise and less painful injections compared to the earlier syringe methods. Despite being easier to use, insulin pens still required manual effort from the user to measure and inject insulin. So, people also use insulin as these equipment’s deliver insulin continuously throughout the day (basal rate) and allow patients to administer bolus doses when required, such as before meals. Insulin pumps also deliver personalized insulin therapy. But insulin pumps are worn continuously and are uncomfortable. They also require the user to wear a catheter that can cause skin irritation.
[0004] US4398908A discloses about an invention that includes insulin delivery system comprises insulin reservoir, pump and subcutaneous needle. Pump is electromechanically-driven at a preselectable fixed rate and can be additionally actuated to deliver a preprandial bolus of selected dosage.
[0005] US20150352282A1 discloses about an invention that includes a system is provided with an insulin delivery device configured to deliver insulin to a user of the system and a computer-based control unit associated with the insulin delivery device. The computer-based control unit includes a user interface and a computer-based processor. The computer-based processor is configured to calculate a relative insulin on board value for a specific time by calculating a first value that represents a reference insulin on board value at the specific time, calculating a second value that represents an automated insulin on board value at the specific time, and subtracting one of the first and second values from the other. The automated insulin on board value represents at least one insulin delivery automatically specified by the computer-based control unit. Methods of use are also disclosed.
[0006] Conventionally, many systems have been developed that are capable of monitoring health parameters of user and delivers insulin. However, these existing systems are incapable of sanitizing the user's skin prior to insulin delivery, which may lead to safety and hygiene concerns during each injection. Additionally, these existing devices lack the ability to provide personalized health suggestions, which impacts the user's lifestyle and overall well-being.
[0007] In order to overcome the aforementioned drawbacks, there exists a need in the art to develop a system that requires to be capable of sanitizing the user’s skin prior to insulin delivery, thereby ensuring safety and hygiene during each injection. In addition, the developed system also needs to offer personalized health suggestions, based on real-time data, thereby enhancing the user's lifestyle and wellbeing.
OBJECTS OF THE INVENTION
[0008] The principal object of the present invention is to overcome the disadvantages of the prior art.
[0009] An object of the present invention is to develop a system that automates delivery of insulin, allowing for a seamless and precise treatment based on individual health needs.
[0010] Another object of the present invention is to develop a system that enables health monitoring in real-time, which considers the user’s medical data, health parameters, and activity levels, to adjust insulin delivery accordingly.
[0011] Yet another object of the present invention is to develop a system that is capable of efficiently locating appropriate injection site, in view of ensuring precise delivery and minimizing discomfort for the user.
[0012] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.
SUMMARY OF THE INVENTION
[0013] The present invention relates to a health monitoring and insulin delivery system that is capable of automating the delivery of insulin to a user, customized according to their medical needs, thereby ensuring optimal dosage and improving user health outcomes.
[0014] According to an embodiment of the present invention, a health monitoring and insulin delivery system, comprises of an elongated member adapted to be worn around a waist of a user, the member is composed of a plurality of section connected with each other by means of hinges, a user interface adapted to be installed with a computing unit to enable the computing unit to connect with a communication unit linked with a microcontroller provided on the member, to input medical details of the user, a circular sliding unit is arranged along the member, a delivery unit is mounted on the sliding unit for delivering insulin to the user, the sliding unit is provided with a sliding rail configured with a plurality of pin joint to enable a curvature of the sliding unit around waist of the user, the delivery unit comprising cuboidal box, an artificial intelligence-based imaging unit, installed on the box to locate abdomen of the user, a chamber is provided within the box to store insulin, connected with an injector by means of a conduit, the injector mounted on the box, for injecting insulin into abdomen of the user, a UV (ultraviolet) lamp is installed on the box for emitting UV light onto user’s abdomen for disinfecting user’s abdomen, a tank is provided in the box for storing isopropyl alcohol, connected with a nozzle mounted on the box to dispense the isopropyl alcohol onto user’s abdomen before injecting insulin, a telescopic gripper provided on the box dabs the isopropyl alcohol over user’s abdomen, and the injector comprises a hollow cylindrical housing having a needle at an end, attached with the box by means of an articulated telescopic rod, receiving the insulin via the conduit, a piston in the attached in the housing by means of a double-rack lever mechanism for pushing the piston for ejecting insulin via the needle.
[0015] According to another embodiment of the present invention, the system further comprises of a flow sensor is configured with the conduit to enable the injector to inject an accurate dose of insulin into the user’s abdomen as per inputted medical details, the rod is regulated based on feedback received by a depth sensor embedded on the box, for detecting depth of needle penetrated into user’s abdomen, a band adapted to be worn over arm of the user, having a sensing unit to detect health parameters of the user and input the parameters into the a dosage module provided with the microcontroller to determine an accurate dosage of insulin based on medical details input by the user and readings of the sensing unit, a touch-enabled display unit is mounted on the band to display readings of the sensing unit for reference of the user, a suggestion module is linked with the microcontroller to generate health suggestion for the user based on data gathered by the sensing unit, the suggestions including dietary and exercise based suggestions, a speaker is mounted on the band to announce the suggestions generated by the suggestion module to the user.
[0016] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates a front view of a health monitoring and insulin delivery system;
Figure 2 illustrates a perspective view of a delivery unit associated with the present invention; and
Figure 3 illustrates a perspective view of a band associated with the present invention system.
DETAILED DESCRIPTION OF THE INVENTION
[0018] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.
[0019] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.
[0020] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.
[0021] The present invention relates to a health monitoring and insulin delivery system that enable the automatic administration of insulin, in view of ensuring smooth and accurate treatment tailored to the specific health requirements of the individual. Additionally, the proposed system also efficiently locating the appropriate injection site, in view of ensuring precise delivery and minimizing discomfort for the user.
[0022] Referring to Figure 1 and 2 a front view of a health monitoring and insulin delivery system and a perspective view of a delivery unit associated with the present invention are illustrated, respectively, comprising an elongated member 101 adapted to be worn around a waist of a user, the member 101 is composed of a plurality of section connected with each other by means of hinges 102, a circular sliding unit 103 is arranged along the member 101, a delivery unit 104 is mounted on the sliding unit 103, the delivery unit 104 comprising cuboidal box 201, an artificial intelligence-based imaging unit 202, installed on the box 201, a chamber 203 is provided within the box 201, an injector 204 is mounted on the box 201, the injector 204 attached with the box 201 by means of an articulated telescopic rod 205, a UV (ultraviolet) lamp 206 is installed on the box 201, the sliding unit 103 is provided with a sliding rail configured with a plurality of pin joint 105, a tank 207 is provided in the box 201 connected with a nozzle 208, a telescopic gripper 209 provided on the box 201.
[0023] The system disclosed herein comprising an elongated member 101 that is designed to be worn around the waist of a user, comprising multiple sections that are interconnected by hinges 102. This structure allows for flexibility and adjustability, ensuring that the member 101 is comfortably fit the user’s waist while maintaining its functionality. The hinged sections enable the member 101 to conform to the user's body shape and size, providing a secure and customized fit.
[0024] The hinges 102 mentioned above is preferably a motorized hinges 102 that involves the use of an electric motor to control the movement of the hinges 102 and the connected component. The hinges 102 provide the pivot point around which the movement occurs. The motor is the core component responsible for generating the rotational motion. It converts the electrical energy into mechanical energy, producing the necessary torque that drives the hinges 102. As the motor rotates, the motorized hinges 102 tilts and conform to the user's body shape and size, providing a secure and customized fit.
[0025] A user interface is configured to be installed with a computing unit, enabling the computing unit to establish a connection with a communication unit that is linked to a microcontroller provided on the elongated member 101. This setup allows the user to input medical details, such as personal health data and treatment specifications, directly into the system. The communication unit facilitates the transmission of the inputted information to the microcontroller, enabling efficient processing and utilization of the data for medical management purposes.
[0026] A circular sliding unit 103 is positioned along the elongated member 101, developed to facilitate the controlled movement of a delivery unit 104 for insulin administration to the user. The sliding unit 103 is configured to allow for smooth and precise linear translation along the member 101, ensuring accurate placement of the delivery unit 104. The delivery unit 104, mounted on this sliding unit 103, is responsible for the delivery of insulin to the user, with the movement of the sliding unit 103 ensuring that the insulin is administered in alignment with the user’s specific requirements.
[0027] The delivery unit 104 comprises a cuboidal box 201, within which an artificial intelligence-based imaging unit 202 is installed. This imaging unit 202 is integrated with a processor to record and process images of the surrounding area. The purpose of this imaging unit 202 is to detect and locate the abdomen of the user, enabling accurate positioning of the insulin delivery arrangement. By utilizing the recorded images and processed data, the microcontroller ensures that the delivery unit 104 is properly aligned with the user’s abdomen for precise and effective insulin administration.
[0028] The imaging unit 202 disclosed herein comprises of an image capturing arrangement including a set of lenses that captures multiple images of the surroundings and the captured images are stored within memory of the imaging unit 202 in form of an optical data. The imaging unit 202 also comprises of the processor which processes the captured images.
[0029] This pre-processing involves tasks such as noise reduction, image stabilization, or color correction. The processed data is fed into AI protocols for analysis which utilizes machine learning techniques, such as deep learning neural networks, to extract meaningful information from the visual data which are processed by the microcontroller to locate abdomen of the user.
[0030] As the abdomen of the user is located, the microcontroller synchronously actuates the sliding unit 103. The circular sliding unit 103, herein discloses consist of a motorized carriage attached to a circular rail to provide rotation to the first portion. Upon actuation of the motorized slider by the microcontroller, the motor drives the carriage along the circular rail, facilitating a smooth and precise circular sliding motion of the delivery unit 104 towards abdomen of the user.
[0031] The sliding unit 103 is equipped with a sliding rail, which is configured with a plurality of pin joint 105. These pin joint 105 allow for the flexible movement of the sliding unit 103, enabling it to adapt to the curvature of the user’s waist. The pin joint 105 permit the sliding rail to follow the natural contour of the body, ensuring that the sliding unit 103 moves smoothly and accurately during the delivery process.
[0032] The pin joint 105 comprises of a ring and cylindrical portion that are linked with each other to provide rotational movement to the sliding unit 103. The ring is powered by a motor that is activated by the microcontroller to the rotate the ring to move the cylindrical portion due to which the sliding unit 103 tilts. The motor is typically controlled by an electronic control unit that regulates its speed and direction. The joint consists of a hinge mechanism that enables rotation of the shaft that results in the rotational motion of the sliding unit 103 around waist of the user.
[0033] A chamber 203 is incorporated within the box 201 for the storage of insulin, which is connected to an injector 204 through a conduit. The injector 204 is securely mounted on the box 201 and is responsible for delivering the insulin into the user's abdomen. The conduit facilitates the controlled transfer of insulin from the storage chamber 203 to the injector 204. Upon activation, the injector 204 administers the insulin through a needle, ensuring precise and accurate injection into the user’s abdomen, in accordance with the medical requirements as determined by the system.
[0034] Prior actuation of the injector 204, the microcontroller actuates a UV (ultraviolet) lamp 206 that is installed on the box 201. The UV lamp 206 emits ultraviolet light of specific wavelengths, typically in the UVC range, which is known for its germicidal properties. When activated, the lamp 206 directs the UV light toward the user's abdomen. The UV light penetrates the cell walls of microorganisms, damaging their DNA or RNA, thereby preventing their ability to replicate and causing their destruction. This disinfection process occurs within a specified time frame to ensure effective sanitation of the skin before the insulin injection, providing a sterilized surface and reducing the chances of infection.
[0035] A tank 207 is provided within the box 201 for storing isopropyl alcohol, which is connected to a nozzle 208 mounted on the box 201. The purpose of this setup is to dispense the isopropyl alcohol onto the user’s abdomen before the insulin injection. Upon activation, the nozzle 208 releases a controlled amount of isopropyl alcohol, ensuring that the user’s abdomen is disinfected prior to injection. This step enhances hygiene and reduces the risk of infections by ensuring a clean surface for the insulin delivery. The dispenser is configured to release a fine mist or spray of isopropyl alcohol over the abdomen to facilitate disinfection.
[0036] The nozzle 208 operates by regulating the flow of isopropyl alcohol from the tank 207 through a conduit. When activated, the nozzle 208 dispenses the alcohol in a controlled manner, either as a fine mist or spray, onto the user's abdomen. This release is regulated by a microcontroller, which ensures the correct amount of alcohol is dispensed. The nozzle 208 may utilize pressure or an electromagnetic valve to release the alcohol, ensuring precise and even coverage of the abdomen before the insulin injection. This action ensures that the user’s skin is properly disinfected prior to the procedure.
[0037] A telescopic gripper 209 is installed on the box 201 gets pneumatically actuated and extends/retract to position the nozzle 208 in an appropriate position. The pneumatic arrangement of the gripper 209 comprises of a cylinder incorporated with an air piston and the air compressor, wherein the compressor controls discharging of compressed air into the cylinder via air valves which further leads to the extension/retraction of the piston. The piston is attached to the telescopic gripper 209, wherein the extension/retraction of the piston corresponds to the extension/retraction of the gripper 209. The actuated compressor allows extension of the gripper 209 to position the nozzle 208 in an appropriate position.
[0038] The injector 204 is composed of a hollow cylindrical housing that contains a needle at one end, which is responsible for delivering insulin into the user's abdomen. The housing is attached to the box 201 by an articulated telescopic rod 205, which allows for precise positioning of the needle. Insulin is delivered through a conduit connected to the housing. The injector 204 is designed to precisely push the insulin through the needle with the help of a piston, which is driven by a double-rack lever mechanism, ensuring a controlled, accurate injection of insulin into the user’s abdomen.
[0039] The injector 204 functions by receiving insulin via a conduit within the box 201. Upon activation, the piston inside the housing is pushed by a double-rack lever mechanism. This action causes the insulin to be ejected through the needle. The needle is precisely positioned in the user’s abdomen, ensuring accurate delivery. The piston mechanism ensures a consistent flow of insulin, preventing any interruptions or inconsistencies in the dosage.
[0040] The double-rack lever mechanism operates by converting rotational motion into linear motion. Upon activation, the motor or actuator rotates the first rack, which in turn drives the second rack, pushing the piston inside the housing. The piston’s movement forces the insulin through the needle. This mechanism ensures the controlled and consistent flow of insulin, providing precise dosage delivery. The double-rack system minimizes the risk of errors in insulin delivery by ensuring a smooth, stable motion and preventing abrupt movements that alter the dosage.
[0041] A flow sensor is integrated with the conduit connected to the injector 204 to ensure the accurate delivery of insulin to the user’s abdomen. The sensor continuously monitors the flow rate of insulin as it is dispensed from the storage chamber 203 through the conduit. The flow rate data collected by the sensor is transmitted to the microcontroller, which compares it against the required insulin dosage, based on the medical details input by the user. The microcontroller adjusts the injector 204 operation accordingly to guarantee the precise amount of insulin is delivered, ensuring both accuracy and efficiency in the administration of the insulin.
[0042] The flow sensor detects the movement of insulin through the conduit by measuring the rate at which it flows. As insulin moves through the tube, the sensor captures this motion, converting it into electrical signals. These signals are then transmitted to the microcontroller for processing. The microcontroller compares the flow rate with the pre-set required dosage. If any deviation from the expected flow rate is detected, the microcontroller adjusts the injector 204 operation to ensure the correct dose is administered. This continuous monitoring ensures precise insulin delivery based on the user’s medical details and requirements.
[0043] The rod 205 is pneumatically actuated, wherein the pneumatic arrangement of the rod 205 comprises of a cylinder incorporated with an air piston and the air compressor, wherein the compressor controls discharging of compressed air into the cylinder via air valves which further leads to the extension/retraction of the piston. The piston is attached to the telescopic rod 205, wherein the extension/retraction of the piston corresponds to the extension/retraction of the rod 205. The actuated compressor allows extension of the rod 205 to position the injector 204 in an appropriate position for precise delivery of the insulin.
[0044] The rod 205 function is regulated by the microcontroller based on depth of needle penetrated into user’s abdomen which is determined via a depth sensor embedded on the box 201. The depth sensor operates by emitting signals that measure the distance between the sensor and the surface of the user's skin. As the needle is inserted into the abdomen, the sensor detects the amount of penetration and sends this data to the microcontroller. The microcontroller uses this information to adjust the movement of the articulated telescopic rod 205, ensuring that the needle is inserted to the correct depth. This feedback loop allows for precise needle placement and ensures proper insulin delivery without damaging surrounding tissues.
[0045] Referring to Figure 3, a perspective view of a band associated with the present invention is illustrated, comprising a band 301 adapted to be worn over arm of the user, having a sensing unit comprises a temperature sensor 302, a cortisol monitor 303, an FBG (fiber Bragg grating) sensor 304, an artificial intelligence-based camera 305, a speaker 306 is mounted on the band 301, a touch-enabled display unit 307 is mounted on the band 301.
[0046] A band 301 is to be worn over the user’s arm, houses a sensing unit equipped with multiple sensors. These sensors include a temperature sensor 302 for monitoring the user’s body temperature, a cortisol monitor 303 for measuring the user’s cortisol levels, and an FBG (fiber Bragg grating) sensor 304 to detect cardiovascular activity, enabling the estimation of calories burned. Additionally, the band 301 features an artificial intelligence-based camera 305, which records the user’s food consumption. The collected data is transmitted to a dosage module integrated with a microcontroller, which processes the information along with the user’s medical details to determine the precise insulin dosage required.
[0047] The temperature sensor 302 continuously monitors the user's body temperature by detecting infrared radiation emitted from the skin's surface. The temperature sensor 302 converts the detected radiation into an electrical signal, which is then processed by the sensor 302 internal circuitry. The signal is compared to a pre-calibrated reference value to determine the precise body temperature. This value is transmitted to the dosage module for further analysis.
[0048] The cortisol monitors 303 measures the cortisol levels in the user’s bloodstream through a non-invasive means, such as sweat or skin temperature variations. When cortisol levels are measured, the sensor converts the biochemical data into a corresponding electrical signal. This signal is then transmitted to the dosage module.
[0049] The FBG (fiber Bragg grating) sensor 304 detects changes in the user’s cardiovascular activity by measuring the strain and pressure in the skin through optical fibres embedded with a series of grating patterns. When the skin deforms due to pulsations of the cardiovascular system, the grating pattern shifts. This shift causes changes in the light reflected from the fibre. The sensor 304 detects these changes in reflection and converts them into an electrical signal. The sensor 304 continuously monitors the cardiovascular signals, and the collected data is used to estimate the calories burned, transmitting the information for further analysis by the microcontroller.
[0050] The artificial intelligence-based camera 305 utilizes computer vision protocols to analyze visual data captured by the camera 305. The artificial intelligence-based camera 305 scans the food items consumed by the user by identifying and classifying food through image recognition. The camera 305 processes the image data in real-time, using pre-trained machine learning models to recognize various food types and their nutritional content. The detected food information, including portion size and caloric value, is then transmitted to the microcontroller for further processing. The microcontroller integrates the food consumption data with other health parameters to adjust insulin dosage accurately.
[0051] Simultaneously, the dosage module processes above data received from sensors and camera 305 to calculate the user’s insulin requirements. The module uses protocols that take into account the user’s medical details, such as their insulin sensitivity, blood glucose levels, and other health parameters. Based on these inputs, the module determines the precise amount of insulin required and communicates this to the system. The dosage module continuously updates its calculations in response to real-time changes in the user’s health data, ensuring accurate insulin delivery.
[0052] The band 301 is installed with a touch-enabled display unit 307 that display readings of the sensing unit for reference of the user. The display unit 307 comprises an LED or LCD screen, a control board, a backlight arrangement, and input connectors. The LED/LCD screen serves as the main visual output, while the control board manages data input and image processing. The backlight arrangement, often made of LEDs, illuminates the screen, ensuring visibility. When information is sent to the display, the control board processes the data and directs the LED/LCD pixels to show specific colors, creating images or text. The backlight adjusts brightness for optimal clarity. This combined functionality enables the unit to accurately display readings of the sensing unit for reference of the user.
[0053] A suggestion module is interfaced with the microcontroller to generate personalized health recommendations for the user, utilizing data collected by the sensing unit. The module processes the gathered health data to generate suggestions that are tailored to the user's individual needs, which may include dietary adjustments and exercise recommendations. These suggestions are provided to help the user improve their overall health and well-being by incorporating lifestyle changes based on the real-time data from the sensing unit. The generated health suggestions aim to optimize the user's daily routines, promoting better health outcomes and effective management of the user’s condition.
[0054] Further the band 301 is installed with a speaker 306 that announce the suggestions generated by the suggestion module to the user. The speaker 306 disclosed herein works by receiving signals from the microcontroller, converting them into sound waves through a diaphragm’s vibration, and producing audible sounds with the help of amplification and control circuitry in order to provide voice notification regarding suggestions generated by the suggestion module to the user.
[0055] Moreover, a battery is associated with the system for powering up electrical and electronically operated components associated with the system and supplying a voltage to the components. The battery used herein is preferably a Lithium-ion battery which is a rechargeable unit that demands power supply after getting drained. The battery stores the electric current derived from an external source in the form of chemical energy, which when required by the electronic component of the system, derives the required power from the battery for proper functioning of the system.
[0056] The present invention works best in the following manner, where the elongated member 101 as disclosed in the invention is adapted to be worn around the waist of the user. The member 101 is composed of the plurality of section connected with each other by means of hinges 102. The user interface adapted to be installed with the computing unit to enable the computing unit to connect with the communication unit linked with the microcontroller provided on the member 101, to input medical details of the user. The circular sliding unit 103 is arranged along the member 101. The delivery unit 104 is mounted on the sliding unit 103 for delivering insulin to the user. And the sliding unit 103 is configured with the plurality of pin joint 105 to enable the curvature of the sliding unit 103 around waist of the user. The delivery unit 104 comprising cuboidal box 201, the artificial intelligence-based imaging unit 202 that locate abdomen of the user. The chamber 203 to store insulin and is connected with the injector 204 by means of the conduit.
[0057] In continuation, the injector 204 mounted on the box 201, for injecting insulin into abdomen of the user. Prior actuation of the injector 204 the UV (ultraviolet) lamp 206 emits UV light onto user’s abdomen for disinfecting user’s abdomen. The tank 207 is provided in the box 201 for storing isopropyl alcohol, connected with the nozzle 208 to dispense the isopropyl alcohol onto user’s abdomen before injecting insulin. The telescopic gripper 209 dabs the isopropyl alcohol over user’s abdomen. Afterwards the injector 204 ejecting insulin via the needle. Further the band 301 adapted to be worn over arm of the user, having the sensing unit to detect health parameters of the user and input the parameters into the dosage module to determine the accurate dosage of insulin based on medical details input by the user and readings of the sensing unit. The touch-enabled display unit 307 display readings of the sensing unit for reference of the user. The suggestion module is linked with the microcontroller to generate health suggestion for the user based on data gathered by the sensing unit, the suggestions including dietary and exercise-based suggestions. Furthermore, the speaker 306 announces the suggestions generated by the suggestion module to the user.
[0058] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention. , Claims:1) A health monitoring and insulin delivery system, comprising:
i) an elongated member 101 adapted to be worn around a waist of a user, wherein said member 101 is composed of a plurality of section connected with each other by means of hinges 102;
ii) a user interface adapted to be installed with a computing unit to enable said computing unit to connect with a communication unit linked with a microcontroller provided on said member 101, to input medical details of said user;
iii) a circular sliding unit 103 is arranged along said member 101, wherein a delivery unit 104 is mounted on said sliding unit 103 for delivering insulin to said user;
iv) said delivery unit 104 comprising cuboidal box 201, an artificial intelligence-based imaging unit 202, installed on said box 201 and integrated with a processor for recording and processing images in a vicinity of said box 201, to locate abdomen of said user to trigger said microcontroller to actuate said sliding unit 103 to translate said delivery unit 104 towards abdomen of said user, wherein a chamber 203 is provided within said box 201 to store insulin, connected with an injector 204 by means of a conduit, said injector 204 mounted on said box 201, for injecting insulin into abdomen of said user;
v) said injector 204 comprises a hollow cylindrical housing having a needle at an end, attached with said box 201 by means of an articulated telescopic rod 205, receiving said insulin via said conduit, wherein a piston in said attached in said housing by means of a double-rack lever mechanism for pushing said piston for ejecting insulin via said needle;
vi) a band 301 adapted to be worn over arm of said user, having a sensing unit to detect health parameters of said user and input said parameters into said a dosage module provided with said microcontroller to determine an accurate dosage of insulin based on medical details input by said user and readings of said sensing unit.
2) The system as claimed in claim 1, wherein a flow sensor is configured with said conduit to enable said injector 204 to inject an accurate dose of insulin into said user’s abdomen as per inputted medical details.
3) The system as claimed in claim 1, wherein said rod 205 is actuated based on feedback received by a depth sensor embedded on said box 201, for detecting depth of needle penetrated into user’s abdomen.
4) The system as claimed in claim 1, wherein a UV (ultraviolet) lamp 206 is installed on said box 201 for emitting UV light onto user’s abdomen for disinfecting user’s abdomen.
5) The system as claimed in claim 1, wherein said sliding unit 103 is provided with a sliding rail configured with a plurality of pin joint 105 to enable a curvature of said sliding unit 103 around waist of said user.
6) The system as claimed in claim 1, wherein a tank 207 is provided in said box 201 for storing isopropyl alcohol, connected with a nozzle 208 mounted on said box 201 to dispense said isopropyl alcohol onto user’s abdomen before injecting insulin, wherein a telescopic gripper 209 provided on said box 201 dabs said isopropyl alcohol over user’s abdomen.
7) The system as claimed in claim 1, wherein said sensing unit comprises a temperature sensor 302 for detecting temperature of said user, a cortisol monitors 303 for detecting a cortisol level of said user, an FBG (fiber Bragg grating) sensor 304 or detecting cardiovascular activity of said user to enable an estimation of calories burned by said user, an artificial intelligence-based camera 305 for recording a food consumed by said user.
8) The system as claimed in claim 1, wherein a suggestion module is linked with said microcontroller to generate health suggestion for said user based on data gathered by said sensing unit, said suggestions including dietary and exercise-based suggestions.
9) The system as claimed in claim 1, wherein a speaker 306 is mounted on said band 301 to announce said suggestions generated by said suggestion module to said user.
10) The system as claimed in claim 1, wherein a touch-enabled display unit 307 is mounted on said band 301 to display readings of said sensing unit for reference of said user.
| # | Name | Date |
|---|---|---|
| 1 | 202521024794-STATEMENT OF UNDERTAKING (FORM 3) [19-03-2025(online)].pdf | 2025-03-19 |
| 2 | 202521024794-REQUEST FOR EXAMINATION (FORM-18) [19-03-2025(online)].pdf | 2025-03-19 |
| 3 | 202521024794-REQUEST FOR EARLY PUBLICATION(FORM-9) [19-03-2025(online)].pdf | 2025-03-19 |
| 4 | 202521024794-PROOF OF RIGHT [19-03-2025(online)].pdf | 2025-03-19 |
| 5 | 202521024794-POWER OF AUTHORITY [19-03-2025(online)].pdf | 2025-03-19 |
| 6 | 202521024794-FORM-9 [19-03-2025(online)].pdf | 2025-03-19 |
| 7 | 202521024794-FORM FOR SMALL ENTITY(FORM-28) [19-03-2025(online)].pdf | 2025-03-19 |
| 8 | 202521024794-FORM 18 [19-03-2025(online)].pdf | 2025-03-19 |
| 9 | 202521024794-FORM 1 [19-03-2025(online)].pdf | 2025-03-19 |
| 10 | 202521024794-FIGURE OF ABSTRACT [19-03-2025(online)].pdf | 2025-03-19 |
| 11 | 202521024794-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [19-03-2025(online)].pdf | 2025-03-19 |
| 12 | 202521024794-EVIDENCE FOR REGISTRATION UNDER SSI [19-03-2025(online)].pdf | 2025-03-19 |
| 13 | 202521024794-EDUCATIONAL INSTITUTION(S) [19-03-2025(online)].pdf | 2025-03-19 |
| 14 | 202521024794-DRAWINGS [19-03-2025(online)].pdf | 2025-03-19 |
| 15 | 202521024794-DECLARATION OF INVENTORSHIP (FORM 5) [19-03-2025(online)].pdf | 2025-03-19 |
| 16 | 202521024794-COMPLETE SPECIFICATION [19-03-2025(online)].pdf | 2025-03-19 |
| 17 | Abstract.jpg | 2025-03-26 |
| 18 | 202521024794-FORM-26 [03-06-2025(online)].pdf | 2025-06-03 |